This study aimed to evaluate influence of ethnic factors on the pharmacokinetics of orally inhaled QMF@ , a novel combination of an approved longacting @-agonist , indacaterol ( Onbrez Breezhaler for COPD ) , and an approved inhaled corticosteroid , mometasone furoate ( MF ) , ( Asmanex Twisthaler for asthma ) , following multiple dose administration of QMF@ ( indacaterol acetate/MF ) @/@ g and @/@ g via the Breezhaler device in healthy Japanese and Caucasian subjects .